Actuant was downgraded at Baird from outperform to neutral. Valuation call, based on a $33 price target. Stock has made a good run, but end-market strength remains uncertain, Robert Baird said.
Auxilium Pharmaceuticals was upgraded to hold at TheStreet Ratings.
Bruker upgraded at Jefferies from hold to buy. $25 price target. Company has a better near-term profit outlook, Jefferies said.
Cover-All Technologies was downgraded to sell at TheStreet Ratings.
Legg Mason was upgraded at Wells Fargo from market perform to outperform. Estimates also boosted, given a better flow and performance picture, Wells Fargo said.
Williams-Sonoma downgraded at Deutsche Bank from buy to hold. $49 price target. Valuation call, as margins could contract in 2013, Deutsche Bank said.
Yahoo! was upgraded at Oppenheimer from perform to outperform. $27 price target. Japanese business is gaining in value and Alibaba will likely have an IPO in the next year, Oppenheimer said.
STOCK COMMENTS/EPS CHANGES
FedEx estimates, target cut at Jefferies. Shares of FDX now seen reaching $100. Company has excess capacity and is seeing customer trade down, according to Jefferies. Hold rating.
General Mills estimates were raised through 2014 at Jefferies. Company is seeing higher sales growth and spending less on advertising, Jefferies said. Hold rating and new $44 price target.
General Mills price target and earnings increased at UBS. Earnings estimates were increased to reflect improving domestic fundamentals, favorable food inflation and better than expected accretion from recent acquisitions, said UBS. Price target is $47.
Intel price target and estimates through 2014 were cut at Citi. The Chinese New Year had poor PC demand and the effects of the Haswell launch will impact business, said Citigroup. Price target is $23.
Jabil earnings estimates were reduced at UBS.. Guidance was lighter than expected as end markets remain tough, said UBS. Price target remains $23.
Oracle earnings estimates were reduced through 2014 at Citi. The numbers reflect lower HW revenue and also a build off of lower comp into February 2014, said Citigroup. Price target remains $38.
Plantronics estimates, target boosted at JP Morgan. Shares of PLT now seen reaching $48.50, according to JP Morgan. Estimates also upped, given higher mobile demand. Overweight rating.
Synaptics estimates, target were raised at Sterne Agee. Shares are now seen reaching $45, according to Sterne Agee. Estimates also increased, as the company appears to have won share in the Galaxy S4. Buy rating.
>To submit a news tip, email: firstname.lastname@example.org.